Design of metastable β-sheet oligomers from natively unstructured peptide

Marcos J. Guerrero-Muñoz, Diana L. Castillo-Carranza, Urmi Sengupta, Mark A. White, Rakez Kayed

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Amyloid oligomers represent the primary pathological species for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Toxic oligomers are formed by many different proteins and peptides, but their polydispersity makes them highly dynamic and heterogeneous. One way to stabilize these structures is to prepare constrained peptides that can be used to study amyloid intermediates, to identify oligomer-specific drugs, and to generate conformational antibodies. These conformational antibodies have demonstrated that oligomers share a common epitope. In this research, we used a 40-amino acid unstructured segment of prion protein (Prp) 109-148 with substitutions of methionine for glycine (Prp-G) residues to prepare a stable and homogeneous population of β-sheet oligomer mimics. These structures were characterized by multiple biophysical and biochemical techniques that show characteristic features of oligomers. Finally, this preparation was not detected by three different sequence dependent prion antibodies.

Original languageEnglish (US)
Pages (from-to)1520-1523
Number of pages4
JournalACS chemical neuroscience
Issue number12
StatePublished - Dec 18 2013


  • Amyloid oligomer
  • constrained peptide
  • prion

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology


Dive into the research topics of 'Design of metastable β-sheet oligomers from natively unstructured peptide'. Together they form a unique fingerprint.

Cite this